Novartis Enters into Deal with Legend Biotech for $100 Million Upfront

Legend Biotech has secured an exclusive global license deal with Novartis giving the Swiss pharma access to Legend’s CAR-T cell therapies. The deal will give Novartis access to CAR-Ts that target the delta-like ligand protein (DLL3) candidate LB2102, which Legend has been investigating to treat adults with certain small cell lung cancers. Novartis will pay […]

Natera Announces Real-World Data Collaboration with Merck

Natera, Inc., a global leader in cell-free DNA testing announced that it has entered into an agreement with Merck, known as MSD outside the United States and Canada, under which Merck will utilize Natera’s real-world database (RWD) to advance oncology research. Natera’s oncology RWD contains de-identified clinical and genomic data from more than 100,000 early- […]

The Role of Nurses In The Pharmaceutical Industry

The healthcare landscape is a tapestry woven with various professional threads, each critical to the overall picture of health and wellness. Among these threads, the role of nurses within the pharmaceutical industry is both vibrant and vital, extending far beyond the traditional confines of medical facilities. This article sheds light on the multifaceted contributions of […]

Hope In Medicine: Treatments That Redefined Healthcare

Medicine is a realm of constant evolution, offering new hope with each discovery. Over the years, medical advancements have transformed the way we approach healthcare. This article delves into the breakthrough treatments that have redefined healthcare, offering hope and changing lives in remarkable ways. The Revolution Of Immunotherapy One of the most remarkable medical revolutions […]

Andelyn Biosciences and The Ohio State University Collaborate for Pre-clinical and GMP Manufacturing of Novel Gene Therapies

Andelyn Biosciences, Inc., a pioneering and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), is collaborating with The Ohio State University Gene Therapy Institute for the development and clinical manufacturing of novel gene therapies. The collaboration was established to facilitate the pathway to bring Ohio State’s investigational gene therapies for a multitude of […]

Elsevier introduces authoritative scientific Datasets to fuel innovation and business-critical decisions in life sciences, chemicals and other research-intensive industries

Elsevier, a global leader in scientific information and data analytics, has announced a new offering of enriched and authoritative scientific Datasets to power data applications that solve R&D challenges. Elsevier’s Datasets enable researchers, data scientists and practice leaders to answer R&D questions with greater speed and precision across many industries, including life sciences, energy, chemicals […]

New Pharma Legislation May Cut Europe R&D Share By One-Third

The European Federation of Pharmaceutical Industries and Associations- EFPIA happens to be consistently applying pressure on the Commission for its pharmaceutical legislation. In a newly published assessment, EFPIA infers that the draft proposals would further speed up the decline of Europe’s position in pharma R&D investment as compared to the US, China, and Japan. The […]

Prange Group and Adragos Pharma to acquire Fresenius Kabi’s manufacturing site in Halden, Norway

Prange Group and its affiliate Adragos Pharma have announced the signing of definitive agreements with Fresenius Kabi for the acquisition of the leading sterile pharmaceutical production site in Halden, Norway. As part of the transaction, Fresenius Kabi will strike a long-term supply agreement for products manufactured at the Halden site. This acquisition marks a significant […]

Hovione acquires ExtremoChem and its portfolio of proprietary sugars to support customers with stabilization and delivery of biopharmaceuticals

Hovione, the specialist integrated CDMO and the leader in spray drying and particle engineering, has announced it has acquired ExtremoChem Lda (ExtremoChem), an innovative start-up company focused on the synthesis, development, and commercialization of bio-inspired synthetic sugars, targeting enhanced stabilization, reduced viscosity and delivery performance of proteins and other biopharmaceuticals. ExtremoChem developed a library of […]

Inizio Launch Elevate Set to Help Global Pharma Maximize Product Launch Potential

Market-leading commercialization platform, Inizio, has announced ‘Inizio Launch Elevate’, a connected suite of its best-in-class capabilities designed to accelerate and simplify product launches for global pharma and biotech companies. Inizio Launch Elevate combines deep market and patient insights, launch strategy expertise, and rigorous cross-functional execution to ensure relentless alignment throughout the product launch process. Successful […]